Core Viewpoint - Rosen Law Firm is reminding investors who purchased Synopsys, Inc. securities between December 4, 2024, and September 9, 2025, of the December 30, 2025, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Synopsys securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The deadline to move the Court to serve as lead plaintiff is December 30, 2025 [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. Group 3: Case Allegations - The lawsuit alleges that Synopsys' management made materially false and misleading statements and failed to disclose adverse facts about the company's business and operations [5]. - Specific allegations include the negative impact of Synopsys' focus on artificial intelligence customers on its Design IP business and the misleading nature of positive statements made by the defendants regarding the company's prospects [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Skye Bioscience, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - The Class Period for the Skye Bioscience securities is from November 4, 2024, to October 3, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 16, 2026 [2]. Group 2: Legal Representation - Investors are encouraged to select qualified counsel with a successful track record in securities class actions [3]. - Rosen Law Firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company and has been ranked highly for its performance in this area [3]. Group 3: Case Allegations - The lawsuit alleges that Skye Bioscience made materially false and misleading statements regarding its business and the effectiveness of its product, nimacimab [4]. - Specific claims include that nimacimab was less effective than represented, and its clinical and commercial prospects were overstated [4]. - The lawsuit claims that investors suffered damages when the true details about the product were revealed [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Primo Water Corporation and Primo Brands Corporation during specified periods about a class action lawsuit and the upcoming lead plaintiff deadline on January 12, 2026 [1][2]. Group 1: Class Action Details - Investors who purchased Primo Brands securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The lawsuit claims that defendants misrepresented and failed to disclose key facts about the merger between Primo Water and BlueTriton Brands, leading to investor damages when the true details emerged [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [4].

Core Viewpoint - Rosen Law Firm is encouraging investors of Skye Bioscience, Inc. to secure legal counsel before the January 16, 2026 deadline for a class action lawsuit related to securities purchased between November 4, 2024, and October 3, 2025 [2][3]. Group 1: Class Action Details - Investors who purchased Skye securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 16, 2026 [4]. - The lawsuit alleges that defendants made materially false and misleading statements regarding Skye's business and the effectiveness of its product, nimacimab, which led to investor damages when the truth was revealed [6]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [5]. - The firm has been consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [5].

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Sprouts Farmers Market, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SFMDecember 02, 2025 8:16 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - December 2, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action on behalf of purchasers of securities and sellers of put options of Sprouts Farmers Market, Inc. (NASDAQ: SFM) between June 4, 2025 a ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Perrigo Company plc securities between February 27, 2023, and November 4, 2025, of the January 16, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Perrigo securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5]. - The lead plaintiff must file a motion with the court by January 16, 2026, to represent other class members [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [3]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, which suffered from significant underinvestment and required substantial capital expenditures [4]. - It is claimed that there were significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results [4]. - The lawsuit asserts that the positive statements made by Perrigo about its business operations were materially misleading and lacked a reasonable basis, resulting in investor damages when the true details emerged [4].

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Alexandria Real Estate Equities, Inc. (NYSE: ARE) between January 27, 2025 and October 27, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 26, 2026. SO WHAT: If you purchased Alexandria Real Estate Equit ...

Accessibility StatementSkip Navigation Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Dec. 1, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of CS Disco, Inc. (NYSE: LAW) breached their fiduciary duties to shareholders. more press release views with Request a Demo Also from this source HALPER SADEH LLC ENCOURAGES BLUE RIDGE BANKSHARES, INC. SHAREHOLDERS TO CONTACT T ...

Core Points - Rosen Law Firm is reminding investors of Freeport-McMoRan Inc. (NYSE: FCX) about the January 12, 2026 deadline to join a securities class action lawsuit related to purchases made between February 15, 2022, and September 24, 2025 [2][3][6] Group 1: Class Action Details - Investors who purchased Freeport-McMoRan securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3][4] - The lawsuit alleges that Freeport-McMoRan made false and misleading statements regarding safety at the Grasberg Block Cave mine in Indonesia, which led to increased risks for workers and potential regulatory and reputational issues [6] Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience or resources [5] - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [5]

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of investors who purchased securities of Alexandria Real Estate Equities, Inc. during the specified Class Period, highlighting the importance for investors to secure legal counsel before the deadline for lead plaintiff applications [2][3]. Group 1: Class Action Details - The class action lawsuit pertains to securities purchased between January 27, 2025, and October 27, 2025, and aims to address potential compensation for affected investors without upfront costs [2][3]. - Investors wishing to serve as lead plaintiffs must file their motion by January 26, 2026, to represent other class members in the litigation [4]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, noting their history of significant settlements and recognition in the field [5]. - The firm has achieved notable success, including the largest securities class action settlement against a Chinese company and recovering over $438 million for investors in 2019 alone [5]. Group 3: Case Allegations - The lawsuit alleges that defendants provided misleading information regarding Alexandria Real Estate's expected revenue and funds from operations growth for the 2025 fiscal year, particularly concerning its Long Island City property [6][7]. - It is claimed that while presenting positive statements about leasing activity and occupancy stability, the defendants concealed adverse facts about the true state of the Long Island City property, leading to investor damages when the actual situation became known [7].